Metagenomi Receives Award From Cystic Fibrosis Foundation to Explore Novel Gene Editing Systems for Therapeutic Applications for Cystic Fibrosis
Metagenomi , a gene editing company, today announced that it has received an award from the Cystic Fibrosis Foundation to identify and evaluate novel gene editing systems for the development of therapeutics to treat cystic fibrosis.